Amorcyte Cardiac Cell Therapy Trial Passes First Stage and Opens Two New Sites
Stem cell therapy trial proceeds to next stage and opens in two new clinical centers HACKENSACK, N.J. -- Amorcyte, Inc. (Amorcyte), a privately funded biotechnology company developing cell therapy products to treat cardiovascular disease, announced …